Your session is about to expire
← Back to Search
Regional Anesthesia for Cardiogenic Shock
Study Summary
This trial will explore using regional anesthesia to help place a temporary mechanical support device in patients with cardiogenic shock, avoiding need for general anesthetic & supporting a quicker recovery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a clear airway and no difficulty breathing.I have no history of nerve damage where the nerve block will be done.I do not have paralysis on the opposite side of my diaphragm.I need more than 6 liters of oxygen per minute.I can lay down flat comfortably.I do not have any infections near the treatment area.The ultrasound images for the heart are very clear and detailed.I cannot lay flat comfortably or follow instructions well.My heart can be easily reached for a pump placement surgery.You have an ongoing infection in the area being studied.I do not want to receive MAC during my procedure.You have a body mass index (BMI) higher than 30.The neck does not show signs of hostility or aggression.I am under 60 years old and my BMI is below 30.I do not need more than 6 liters of oxygen per minute.I do not want regional anesthesia.It is difficult to see the heart or blood vessels clearly using ultrasound.You have a known or expected problem with breathing during the study.I understand and can follow the study's procedures.High-quality ultrasound images are needed for nerve blocks.My risk of airway blockage is low.I agree to have a nerve block.
- Group 1: Treatment Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any qualifications or criteria required to join this trial?
"The requirements to enroll in this medical trial include cardiogenic shock and an age between 18-60. At the moment, around 10 participants are being sought out."
Is this research restricted to individuals over a certain age limit?
"Qualifying participants must be 18 or older, yet not exceed the age of 60."
Are there available slots for participants in this research project?
"The clinicaltrials.gov repository indicates that, unfortunately, this medical trial is no longer recruiting patients - the study was initially posted on August 1st 2023 and last updated 3/22/2023. Nevertheless, 145 alternative research trials are currently welcoming participants to join their investigations."
Share this study with friends
Copy Link
Messenger